New Metabolic Health Ingredient Targets Abdominal Fat, as Demand Grows for Evidence-Based Solutions

There has been growing consumer interest in metabolic health, so much so that it’s shaping the development of new ingredients across the dietary supplement and functional food sectors. Metabolic health’s complexity extends beyond just weight management, and as a result, ingredient manufacturers are introducing products designed to address these underlying metabolic processes.

One such ingredient is Re-Vaya, which was recently introduced by Lallemand Bio-Ingredients. According to the manufacturer, the new ingredient is positioned to support metabolic balance, particularly among individuals with excess abdominal fat, reflecting broader market interest in metabolic wellness solutions that extend beyond traditional weight-loss formulations.

Ingredient Development Reflects Growing Focus on Metabolic Biology

Re-Vaya was developed with a focus on evidence-based formulation to address the biological processes associated with metabolic health. In fact, it was designed to respond to evolving expectations among formulators seeking scientifically grounded ingredients.

“Re-Vaya represents a meaningful step forward in how we think about metabolic health,” said Dr. Marcia Da Silva Pinto, PharmD, PhD, category manager with Lallemand Bio-Ingredients, in a company press release.¹ “Our goal is to provide a solution that helps people with excess belly fat find metabolic balance while aligning with expectations around trust, transparency, performance, and responsibility.”

The ingredient’s introduction to the marketplace coincides with a broader shift in the health and wellness industry. Rather than focusing solely on weight loss, companies are increasingly exploring metabolic health strategies that address underlying physiological mechanisms, including energy metabolism, inflammation, and fat distribution.

Metabolic dysfunction has been linked to a range of chronic conditions, including type 2 diabetes, cardiovascular disease, and obesity.²

Proteomics Used to Study Metabolic Pathways in Adipose Tissue

According to information provided by the company, research supporting Re-Vaya used proteomic analysis of adipose tissue, a technique that measures changes in large numbers of proteins simultaneously. Proteomics is increasingly used in metabolic research because it allows scientists to examine how biological pathways related to inflammation, energy metabolism, and cellular signaling change under different physiological conditions.

By analyzing protein expression patterns in adipose tissue, researchers can gain insight into how metabolic pathways function at the molecular level. Such approaches are commonly used to investigate metabolic diseases and obesity-related inflammation.

In this particular case—note Annie Tremblay, PhD, scientific affairs manager and da Silva Pinto—human volunteers provided belly‑fat biopsies before and after taking Re-Vaya daily for 28 days. Then, scientists measured hundreds of proteins, revealing a reduction in immune-adipose communication distress signals and increase in mitochondrial energy utilization pathways.³ 

The way immune and adipose cells communicate is at the core of metabolic balance. When their conversation becomes distressed, metabolic imbalance sets in. After taking Re-Vaya, there was indication of a more balanced immune-adipose communication through a reduction in inflammatory stress markers and adipose distress signals.

At the same time, mitochondrial energy pathways were upregulated, which suggests that cells are using fats to produce energy. The clinical study involved 15 individuals, part of a demographic suggesting an unbalanced metabolic/immune communication, based on their age and BMI.

Broad Formulation Potential Across Supplements and Functional Foods

Re-Vaya can reportedly be incorporated into a range of delivery formats, including capsules, tablets, gummies, powders, and functional food and beverage applications. The introduction of new metabolic health ingredients comes as the supplement industry continues to expand offerings addressing metabolic wellness.

Consumer messaging around metabolic health is evolving as well. Rather than emphasizing rapid weight loss, newer product positioning increasingly focuses on metabolic balance, energy regulation, and long-term wellness.

Many emerging metabolic health ingredients require additional clinical evidence to substantiate claims regarding their efficacy and mechanisms of action. Peer-reviewed human clinical trials remain the gold standard for evaluating such interventions.

As ingredient developers continue exploring metabolic pathways, the intersection of nutritional science, molecular biology, and consumer health trends is likely to drive further innovation in the natural products sector.

References

1. Re-Vaya introduced as a new approach to metabolic health. Lallemand Bio-Ingredients. Press release provided via email. March 9, 2026. Accessed March 18. 2026.

2. Metabolic Syndrome. Johns Hopkins Medicine. Accessed March 12, 2026. https://www.hopkinsmedicine.org/health/conditions-and-diseases/metabolic-syndrome

3. Pritchard J, Struszczak L, Henry C, Lugtmeijer C, Bowtell J and O’Leary M (2025) Modulation of adipose inflammation and mitochondrial pathways by a yeast-derived β-1,3/1,6-glucan and vitamin complex: an open-label pilot study of Lalmin immune pro in older overweight adults. Front. Nutr. 12:1656798. doi: 10.3389/fnut.2025.1656798